Internal Reference Pricing
Internal Reference Pricing is a pricing strategy within health economics and policy that sets a reimbursement or payment benchmark for a pharmaceutical or medical product based on the prices of other therapeutically similar products within the same market or formulary, distinguished by its reliance on domestic or internally available price data rather than external international benchmarks.
58
Publications
6.4K
Citations
141
Authors
102
Institutions
Publications per year
2017–2026
11
Parents
58
Policies for biosimilar uptake in Europe: An overview
Evelien Moorkens, Arnold G. Vulto, Isabelle Huys et al. · PLoS ONE · 2017 · 352 citations · Full text
A Range Theory Account of Price Perception
Chris Janiszewski, Donald R. Lichtenstein · Journal of Consumer Research · 1999 · 336 citations
1–5 of 58
141
4
h-index
3
h-index
3
h-index
3
h-index
3
h-index
1–5 of 141
102
Curtin University
Perth, Australia
4 h-index
9 publications
397 citations
University of Miami
Coral Gables, United States
3 h-index
3 publications
2.8K citations

Pennsylvania State University
State College, United States
3 h-index
4 publications
127 citations
University of Nevada, Las Vegas
Las Vegas, United States
3 h-index
4 publications
140 citations
University of Minnesota, Duluth
Duluth, United States
2 h-index
3 publications
59 citations
University of California, Berkeley
Berkeley, United States
2 h-index
2 publications
166 citations
Carnegie Mellon University
Pittsburgh, United States
2 h-index
2 publications
166 citations
California Polytechnic State University
San Luis Obispo, United States
2 h-index
3 publications
4.1K citations
1–8 of 102
7 publications · 473 citations
7
h-index
JCR · 4 publications · 939 citations
4
h-index
3 publications · 339 citations
3
h-index
3 publications · 60 citations
3
h-index
3 publications · 190 citations
3
h-index
1–5